data_6sft_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6sft _Structure_validation_residue.Date_analyzed 2020-06-05 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.32 130.68 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -116.28 110.31 18.57 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.851 0.358 . . . . 0.0 111.283 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.19 152.52 44.4 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.55 -40.15 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.23 -25.84 15.65 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.393 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -118.51 126.37 51.86 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.505 0.503 . . . . 0.0 111.261 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.1 t -132.64 119.31 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 148.9 -174.3 28.57 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.8 155.39 68.82 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 C-N-CA 122.614 2.21 . . . . 0.0 112.293 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -64.58 127.65 32.42 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.2 1.0 . . . . 0.0 112.459 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -78.36 -1.08 31.6 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.076 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -92.73 132.18 37.16 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.788 0.435 . . . . 0.0 110.473 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -155.41 -13.03 0.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.227 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 10.7 t80 . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.809 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.52 130.17 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.34 109.5 17.44 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.65 154.65 39.06 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.18 -37.62 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -176.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.42 -25.78 14.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.599 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -118.65 128.73 54.8 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.695 0.622 . . . . 0.0 111.744 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 54.8 t -134.46 119.22 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.65 -177.58 25.83 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.85 153.53 56.25 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 122.383 2.056 . . . . 0.0 113.035 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -65.48 126.04 27.06 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.665 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -77.11 -1.06 27.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.048 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -94.69 133.33 38.48 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.046 0.539 . . . . 0.0 110.769 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 27.7 ttp-105 -155.61 -10.45 0.11 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.383 0.673 . . . . 0.0 109.262 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.025 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.69 131.63 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -116.41 109.06 16.82 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.828 0.347 . . . . 0.0 110.884 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.99 153.81 40.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.6 m -55.32 -38.26 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.62 -25.72 14.63 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.416 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -118.88 127.77 53.82 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.602 0.564 . . . . 0.0 111.88 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.22 119.32 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 146.32 -176.62 25.15 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.06 151.7 70.58 Favored 'Trans proline' 0 N--CA 1.507 2.317 0 C-N-CA 122.417 2.078 . . . . 0.0 112.854 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -64.38 129.48 40.07 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.743 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -78.99 -1.1 33.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.872 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -95.55 131.77 41.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.228 0.611 . . . . 0.0 110.681 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -155.74 -7.57 0.12 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.257 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.8 t80 . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.547 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 38.1 t-105 . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.58 129.9 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -116.19 108.31 15.98 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 117.672 0.215 . . . . 0.0 110.677 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.21 152.1 41.59 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.3 m -55.56 -40.08 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.7 -25.55 16.06 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.818 0.281 . . . . 0.0 111.748 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -118.62 126.18 51.38 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.575 0.547 . . . . 0.0 111.375 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 52.7 t -130.78 119.33 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 144.06 -177.12 22.94 Favored Glycine 0 CA--C 1.538 1.499 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.4 153.94 50.63 Favored 'Trans proline' 0 N--CA 1.513 2.656 0 C-N-CA 122.891 2.394 . . . . 0.0 113.599 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -65.2 128.31 35.28 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.364 1.065 . . . . 0.0 112.41 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -81.0 -1.0 42.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -92.94 129.44 38.85 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.914 0.486 . . . . 0.0 110.857 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -155.95 -9.53 0.11 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.377 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.15 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.44 129.19 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.46 108.95 16.66 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.82 153.61 40.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.3 p -55.31 -39.27 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.77 -25.74 14.95 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.972 0.351 . . . . 0.0 111.539 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -118.21 126.62 52.56 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.579 0.549 . . . . 0.0 111.576 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.66 119.57 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.88 -175.88 26.99 Favored Glycine 0 CA--C 1.536 1.349 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.1 157.07 63.52 Favored 'Trans proline' 0 N--CA 1.508 2.34 0 C-N-CA 122.546 2.164 . . . . 0.0 112.431 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -64.96 126.18 27.2 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.299 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -77.82 -1.02 29.5 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.027 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -92.89 129.87 38.66 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.881 0.472 . . . . 0.0 110.576 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -150.36 -11.91 0.25 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.4 t80 . . . . . 0 N--CA 1.472 0.665 0 C-N-CA 123.868 0.867 . . . . 0.0 108.817 178.739 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.84 132.23 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -116.25 109.22 17.11 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 120.541 0.21 . . . . 0.0 110.952 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.03 153.19 40.18 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.33 -38.95 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.14 -25.53 14.88 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.866 0.303 . . . . 0.0 111.455 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -118.05 126.39 52.2 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.665 0.603 . . . . 0.0 111.551 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.6 t -132.3 119.26 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.73 -175.08 27.24 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.26 154.84 72.93 Favored 'Trans proline' 0 N--CA 1.506 2.243 0 C-N-CA 122.411 2.074 . . . . 0.0 112.36 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -64.36 128.56 36.3 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.338 1.055 . . . . 0.0 112.271 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -80.0 -1.03 37.88 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.778 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -94.59 131.64 40.15 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.059 0.544 . . . . 0.0 110.468 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -155.8 -9.84 0.11 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.745 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.0 t80 . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.984 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.77 127.95 75.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.903 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -116.63 110.98 19.22 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 120.952 0.406 . . . . 0.0 110.486 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.41 156.22 37.49 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.9 m -55.47 -40.43 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.68 -25.56 15.51 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.337 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -118.64 128.34 54.44 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.737 0.648 . . . . 0.0 111.872 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.73 119.33 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.7 -174.95 30.69 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 156.45 65.56 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 122.425 2.084 . . . . 0.0 112.124 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.81 123.58 19.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.921 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -76.13 -0.98 23.95 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.826 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -93.39 134.89 35.16 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.997 0.519 . . . . 0.0 109.945 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -154.99 -14.9 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.947 0.499 . . . . 0.0 109.892 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 8.3 t80 . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.738 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.1 129.34 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -116.5 109.88 17.86 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.79 154.99 38.76 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.0 m -55.81 -39.63 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.2 -25.48 15.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.519 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -118.45 128.15 54.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.559 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.3 t -132.57 119.33 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 150.97 -175.36 29.97 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.49 160.59 48.99 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 122.457 2.105 . . . . 0.0 112.315 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.77 125.86 26.11 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.613 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -81.37 -0.73 42.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.064 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -96.88 107.39 19.89 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.274 0.629 . . . . 0.0 110.989 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 34.0 mtm105 -131.15 -6.04 3.87 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.119 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.674 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.82 130.05 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.37 109.52 17.45 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.727 0.239 . . . . 0.0 110.805 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.16 153.11 42.01 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.73 -40.39 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.51 -25.79 16.07 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.517 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -118.38 126.88 53.02 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.514 0.509 . . . . 0.0 111.623 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.6 119.2 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 145.64 -177.63 23.91 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.88 154.24 51.48 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 122.531 2.154 . . . . 0.0 112.909 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -64.75 126.78 29.02 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.146 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -75.94 -1.34 25.08 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.965 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -95.23 132.25 40.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.061 0.544 . . . . 0.0 111.131 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -155.95 -8.69 0.11 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.8 t80 . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.73 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.63 130.28 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.46 109.88 17.88 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 121.098 0.475 . . . . 0.0 111.477 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.74 153.2 41.24 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.8 m -55.47 -39.97 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.09 -25.57 15.83 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.835 0.289 . . . . 0.0 111.494 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -118.93 128.01 54.02 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.594 0.559 . . . . 0.0 111.671 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.6 119.32 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 148.96 -175.16 28.34 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.69 156.77 62.67 Favored 'Trans proline' 0 N--CA 1.508 2.328 0 C-N-CA 122.595 2.196 . . . . 0.0 112.268 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -64.84 125.08 23.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.218 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -77.62 -0.87 28.2 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.906 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -93.67 133.85 36.59 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.822 0.449 . . . . 0.0 110.433 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -155.53 -11.41 0.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.795 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -161.71 75.14 2.37 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -86.33 179.61 3.49 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 122.647 2.232 . . . . 0.0 111.034 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -70.55 -136.04 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 54.15 62.65 2.49 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.598 0.359 . . . . 0.0 111.253 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -126.4 119.25 26.81 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.32 130.68 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -116.28 110.31 18.57 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.851 0.358 . . . . 0.0 111.283 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.19 152.52 44.4 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.55 -40.15 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.23 -25.84 15.65 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.393 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -118.51 126.37 51.86 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.505 0.503 . . . . 0.0 111.261 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.1 t -132.64 119.31 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 148.9 -174.3 28.57 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.8 155.39 68.82 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 C-N-CA 122.614 2.21 . . . . 0.0 112.293 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -64.58 127.65 32.42 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.2 1.0 . . . . 0.0 112.459 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -78.36 -1.08 31.6 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.076 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -92.73 132.18 37.16 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.788 0.435 . . . . 0.0 110.473 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -155.41 -13.03 0.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.227 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -114.46 148.19 38.18 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.444 HD21 ' N ' ' A' ' 160' ' ' SER . 0.3 OUTLIER -146.79 117.42 7.55 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.444 ' N ' HD21 ' A' ' 159' ' ' ASN . 45.2 t -108.51 109.04 20.2 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.249 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.69 -12.01 60.32 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 121.063 1.756 . . . . 0.0 110.586 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -105.57 32.4 4.33 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.328 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -70.54 120.1 15.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.696 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -103.78 99.13 8.91 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 161.28 -179.52 36.66 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.23 134.62 21.33 Favored 'Trans proline' 0 N--CA 1.511 2.525 0 C-N-CA 122.454 2.103 . . . . 0.0 112.122 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -96.18 141.45 29.53 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.9 0.88 . . . . 0.0 108.639 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.12 14.55 1.67 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.634 0.652 . . . . 0.0 111.938 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -94.46 134.88 36.51 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 118.092 0.406 . . . . 0.0 111.59 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -58.89 -31.65 68.79 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.659 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.41 -3.22 35.85 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.037 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -87.59 4.2 44.67 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.18 131.67 43.7 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.424 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 117.969 -1.015 . . . . 0.0 111.009 -179.931 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.53 119.5 57.44 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.56 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -78.64 -124.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.508 2.371 0 C-N-CA 121.706 1.604 . . . . 0.0 111.235 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -146.87 47.6 1.16 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -124.82 43.81 2.94 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.462 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -114.39 119.99 38.82 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.96 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.52 130.17 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.34 109.5 17.44 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.65 154.65 39.06 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.18 -37.62 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -176.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.42 -25.78 14.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.599 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -118.65 128.73 54.8 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.695 0.622 . . . . 0.0 111.744 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 54.8 t -134.46 119.22 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.65 -177.58 25.83 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.85 153.53 56.25 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 122.383 2.056 . . . . 0.0 113.035 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -65.48 126.04 27.06 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.665 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -77.11 -1.06 27.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.048 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -94.69 133.33 38.48 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.046 0.539 . . . . 0.0 110.769 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 27.7 ttp-105 -155.61 -10.45 0.11 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.383 0.673 . . . . 0.0 109.262 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -114.16 148.06 37.86 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.405 HD21 ' N ' ' A' ' 160' ' ' SER . 0.4 OUTLIER -141.72 116.83 9.99 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 177.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.405 ' N ' HD21 ' A' ' 159' ' ' ASN . 47.7 t -108.94 104.61 13.88 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.242 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.6 -11.73 60.27 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 121.177 1.808 . . . . 0.0 110.686 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -105.73 31.96 4.66 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.699 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -70.45 119.04 14.03 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -103.57 99.18 8.99 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 161.93 178.37 35.77 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.45 134.2 20.28 Favored 'Trans proline' 0 N--CA 1.508 2.378 0 C-N-CA 122.304 2.003 . . . . 0.0 111.896 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -97.41 141.54 30.36 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -143.86 15.12 1.74 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.362 0.528 . . . . 0.0 111.734 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.16 133.55 37.55 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.035 0.38 . . . . 0.0 111.632 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -58.3 -30.44 66.66 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.635 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.25 -3.21 38.62 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.157 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -90.19 3.92 52.06 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.45 133.06 42.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.78 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.815 179.581 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -165.24 59.62 0.65 Allowed Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.422 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -81.87 160.47 18.63 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.104 1.869 . . . . 0.0 110.873 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -69.73 -138.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.24 72.51 0.42 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.808 0.443 . . . . 0.0 111.359 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -126.2 120.16 29.33 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.69 131.63 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -116.41 109.06 16.82 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.828 0.347 . . . . 0.0 110.884 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.99 153.81 40.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.6 m -55.32 -38.26 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.62 -25.72 14.63 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.416 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -118.88 127.77 53.82 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.602 0.564 . . . . 0.0 111.88 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.22 119.32 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 146.32 -176.62 25.15 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.06 151.7 70.58 Favored 'Trans proline' 0 N--CA 1.507 2.317 0 C-N-CA 122.417 2.078 . . . . 0.0 112.854 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -64.38 129.48 40.07 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.743 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -78.99 -1.1 33.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.872 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -95.55 131.77 41.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.228 0.611 . . . . 0.0 110.681 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -155.74 -7.57 0.12 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.257 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -114.04 147.98 37.79 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.423 HD21 ' N ' ' A' ' 160' ' ' SER . 0.3 OUTLIER -140.68 116.39 10.26 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.423 ' N ' HD21 ' A' ' 159' ' ' ASN . 43.1 t -108.84 104.79 14.11 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.3 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.73 -11.85 60.27 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 121.185 1.811 . . . . 0.0 110.681 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -106.7 32.43 4.54 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.742 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -67.81 121.69 16.53 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -103.85 99.27 9.04 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 154.57 169.53 19.37 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.52 133.84 57.19 Favored 'Trans proline' 0 N--CA 1.514 2.728 0 C-N-CA 122.193 1.929 . . . . 0.0 112.735 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -97.95 142.1 30.1 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.126 0.97 . . . . 0.0 108.606 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 14.63 2.22 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.735 0.698 . . . . 0.0 112.326 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -93.48 133.7 36.51 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.179 0.445 . . . . 0.0 111.287 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -57.57 -30.78 65.53 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.438 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.59 -2.95 38.33 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.208 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -87.31 4.4 43.0 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.921 0.488 . . . . 0.0 110.151 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -95.78 129.64 42.95 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 118.175 -0.916 . . . . 0.0 110.363 -179.697 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -165.39 67.0 1.17 Allowed Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -81.73 -121.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.133 0 C-N-CA 122.57 2.18 . . . . 0.0 112.791 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -84.44 127.91 34.28 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -177.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 63.24 45.49 5.02 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.215 1.006 . . . . 0.0 112.653 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 38.1 t-105 -127.18 117.76 22.97 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.538 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.58 129.9 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -116.19 108.31 15.98 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 117.672 0.215 . . . . 0.0 110.677 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.21 152.1 41.59 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.3 m -55.56 -40.08 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.7 -25.55 16.06 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.818 0.281 . . . . 0.0 111.748 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -118.62 126.18 51.38 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.575 0.547 . . . . 0.0 111.375 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 52.7 t -130.78 119.33 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 144.06 -177.12 22.94 Favored Glycine 0 CA--C 1.538 1.499 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.4 153.94 50.63 Favored 'Trans proline' 0 N--CA 1.513 2.656 0 C-N-CA 122.891 2.394 . . . . 0.0 113.599 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -65.2 128.31 35.28 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.364 1.065 . . . . 0.0 112.41 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -81.0 -1.0 42.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -92.94 129.44 38.85 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.914 0.486 . . . . 0.0 110.857 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -155.95 -9.53 0.11 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.377 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -114.83 148.05 39.03 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.05 117.96 8.21 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.8 t -108.56 105.81 15.6 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.286 -0.864 . . . . 0.0 109.733 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.79 -11.83 60.51 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.806 1.639 . . . . 0.0 110.971 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -104.45 30.26 5.47 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.056 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -70.6 118.45 13.41 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.792 -0.186 . . . . 0.0 111.319 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -103.55 99.22 9.03 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 158.37 169.51 21.96 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.49 133.53 57.5 Favored 'Trans proline' 0 N--CA 1.516 2.851 0 C-N-CA 122.107 1.871 . . . . 0.0 113.128 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -96.25 141.91 29.03 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.095 0.958 . . . . 0.0 108.604 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.08 14.24 2.24 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 118.607 0.64 . . . . 0.0 112.101 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -96.05 135.36 37.94 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.054 0.454 . . . . 0.0 111.753 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -59.55 -31.06 69.07 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.818 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.55 -3.25 39.7 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.113 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -86.85 4.37 41.55 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.27 130.35 43.38 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.789 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.986 -179.638 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 53.64 76.82 0.49 Allowed Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.438 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.31 171.8 0.52 Allowed 'Trans proline' 0 N--CA 1.513 2.668 0 C-N-CA 122.236 1.957 . . . . 0.0 112.44 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -69.6 125.22 26.06 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.752 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 61.12 44.16 10.4 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.422 0.689 . . . . 0.0 111.68 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -126.66 119.78 27.86 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 123.397 0.436 . . . . 0.0 112.089 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.44 129.19 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.46 108.95 16.66 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.82 153.61 40.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.3 p -55.31 -39.27 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.77 -25.74 14.95 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.972 0.351 . . . . 0.0 111.539 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -118.21 126.62 52.56 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.579 0.549 . . . . 0.0 111.576 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.66 119.57 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.88 -175.88 26.99 Favored Glycine 0 CA--C 1.536 1.349 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.1 157.07 63.52 Favored 'Trans proline' 0 N--CA 1.508 2.34 0 C-N-CA 122.546 2.164 . . . . 0.0 112.431 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -64.96 126.18 27.2 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.299 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -77.82 -1.02 29.5 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.027 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -92.89 129.87 38.66 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.881 0.472 . . . . 0.0 110.576 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 89.9 mtt-85 -150.36 -11.91 0.25 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -114.76 148.0 38.97 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.868 0.867 . . . . 0.0 108.817 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.85 117.27 7.98 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.7 t -108.76 107.29 17.68 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.188 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.29 -11.77 60.36 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 121.142 1.792 . . . . 0.0 110.224 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -105.23 32.7 4.07 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.471 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -69.93 120.1 15.15 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.744 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -103.89 99.07 8.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 159.49 -179.19 35.25 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -73.23 134.31 20.82 Favored 'Trans proline' 0 N--CA 1.509 2.424 0 C-N-CA 122.438 2.092 . . . . 0.0 111.928 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -96.77 141.91 29.42 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.02 15.35 1.9 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 118.557 0.617 . . . . 0.0 112.141 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -95.17 134.86 37.44 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.09 0.405 . . . . 0.0 111.452 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -58.57 -32.05 68.57 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.766 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.39 -3.28 36.15 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.227 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -89.58 4.35 49.64 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.841 0.456 . . . . 0.0 109.833 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.46 133.6 40.68 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.52 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 118.264 -0.874 . . . . 0.0 109.893 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.411 ' H1 ' ' H ' ' A' ' 140' ' ' LYS . 35.9 t . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.411 ' H ' ' H1 ' ' A' ' 139' ' ' SER . 24.9 pttm -69.21 148.69 97.55 Favored Pre-proline 0 CA--C 1.555 1.137 0 CA-C-O 118.867 -0.587 . . . . 0.0 110.347 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.45 170.24 18.72 Favored 'Trans proline' 0 N--CA 1.507 2.316 0 C-N-CA 121.808 1.672 . . . . 0.0 110.563 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -72.69 -134.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 52.03 66.2 1.27 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.563 0.345 . . . . 0.0 110.654 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -126.68 119.72 27.69 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.84 132.23 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -116.25 109.22 17.11 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 120.541 0.21 . . . . 0.0 110.952 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.03 153.19 40.18 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.33 -38.95 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.14 -25.53 14.88 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.866 0.303 . . . . 0.0 111.455 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -118.05 126.39 52.2 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.665 0.603 . . . . 0.0 111.551 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.6 t -132.3 119.26 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.73 -175.08 27.24 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.26 154.84 72.93 Favored 'Trans proline' 0 N--CA 1.506 2.243 0 C-N-CA 122.411 2.074 . . . . 0.0 112.36 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -64.36 128.56 36.3 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.338 1.055 . . . . 0.0 112.271 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -80.0 -1.03 37.88 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.778 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -94.59 131.64 40.15 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.059 0.544 . . . . 0.0 110.468 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 38.6 ptt180 -155.8 -9.84 0.11 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.745 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -114.66 112.77 23.4 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.93 116.61 32.57 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.5 t -108.85 103.83 12.97 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 118.277 -0.868 . . . . 0.0 109.917 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.86 -12.05 60.28 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 120.829 1.65 . . . . 0.0 110.497 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -105.59 31.19 5.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.603 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -73.62 119.3 17.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.978 -0.101 . . . . 0.0 110.952 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -103.76 100.33 10.14 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.173 0.511 . . . . 0.0 110.2 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 160.55 179.47 35.34 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.79 134.62 32.99 Favored 'Trans proline' 0 N--CA 1.516 2.807 0 C-N-CA 122.152 1.901 . . . . 0.0 112.556 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.32 142.1 27.7 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.56 11.25 2.72 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 118.596 0.635 . . . . 0.0 111.447 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -93.83 134.08 36.57 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 120.639 0.257 . . . . 0.0 111.081 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -57.35 -32.1 66.4 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.171 0.588 . . . . 0.0 112.151 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.92 -3.11 33.61 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.33 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.56 4.74 38.8 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.22 0.608 . . . . 0.0 110.164 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -95.96 130.37 42.96 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 118.041 -0.98 . . . . 0.0 111.667 -179.292 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.4 p . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 56.13 60.7 8.17 Favored Pre-proline 0 CA--C 1.555 1.144 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.271 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -88.32 -174.47 1.12 Allowed 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.636 2.224 . . . . 0.0 111.129 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -66.25 -137.62 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.178 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 55.95 53.13 9.59 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 119.092 0.86 . . . . 0.0 110.565 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 -117.26 122.79 44.95 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.77 127.95 75.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.903 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -116.63 110.98 19.22 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 120.952 0.406 . . . . 0.0 110.486 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.41 156.22 37.49 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.9 m -55.47 -40.43 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.68 -25.56 15.51 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.337 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -118.64 128.34 54.44 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.737 0.648 . . . . 0.0 111.872 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.73 119.33 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.7 -174.95 30.69 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 156.45 65.56 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 122.425 2.084 . . . . 0.0 112.124 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.81 123.58 19.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.921 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -76.13 -0.98 23.95 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.826 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -93.39 134.89 35.16 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.997 0.519 . . . . 0.0 109.945 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -154.99 -14.9 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.947 0.499 . . . . 0.0 109.892 -179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -114.4 147.87 38.56 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.72 116.42 12.19 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.4 t -109.05 104.06 13.2 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.391 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.95 -11.84 60.21 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 121.054 1.752 . . . . 0.0 110.909 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -104.93 30.57 5.42 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.141 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -74.27 117.97 16.69 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.666 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -102.9 99.27 9.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 166.51 -179.24 40.58 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.89 132.48 18.48 Favored 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 121.963 1.775 . . . . 0.0 111.414 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -97.69 142.05 29.96 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.062 0.945 . . . . 0.0 108.679 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.13 16.91 1.55 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.453 0.57 . . . . 0.0 111.96 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -97.75 137.49 36.55 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 118.095 0.407 . . . . 0.0 111.611 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -62.04 -28.87 69.9 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.35 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.52 -2.93 48.13 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.81 3.95 51.3 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -98.31 133.94 42.02 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.586 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.627 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 95.4 p . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.446 ' H ' ' CD ' ' A' ' 141' ' ' PRO . 64.3 tttm -163.34 -42.75 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.558 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.446 ' CD ' ' H ' ' A' ' 140' ' ' LYS . 13.1 Cg_endo -94.75 -112.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 122.39 2.06 . . . . 0.0 111.819 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -135.48 -130.83 0.15 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.852 0.861 . . . . 0.0 108.816 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 57.27 47.56 16.64 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 118.425 0.557 . . . . 0.0 109.591 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -119.71 119.9 35.01 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.1 129.34 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -116.5 109.88 17.86 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.79 154.99 38.76 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.0 m -55.81 -39.63 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.2 -25.48 15.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.519 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -118.45 128.15 54.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.559 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.3 t -132.57 119.33 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 150.97 -175.36 29.97 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.49 160.59 48.99 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 122.457 2.105 . . . . 0.0 112.315 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.77 125.86 26.11 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.613 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -81.37 -0.73 42.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.064 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -96.88 107.39 19.89 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.274 0.629 . . . . 0.0 110.989 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 34.0 mtm105 -131.15 -6.04 3.87 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.119 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -114.51 147.88 38.73 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.82 118.65 10.54 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.8 t -108.5 105.9 15.76 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 118.21 -0.9 . . . . 0.0 109.09 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.73 -11.56 60.2 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 120.885 1.675 . . . . 0.0 111.138 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -108.63 30.67 6.26 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.992 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -65.76 117.57 8.36 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -176.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -102.42 99.28 9.32 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 161.75 -179.92 36.82 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.4 132.8 18.18 Favored 'Trans proline' 0 N--CA 1.508 2.381 0 C-N-CA 122.329 2.02 . . . . 0.0 111.781 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -94.6 140.8 29.37 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.58 14.2 2.15 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.334 0.515 . . . . 0.0 111.659 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -93.87 131.38 39.33 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 118.015 0.37 . . . . 0.0 110.787 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -58.31 -27.72 64.36 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.655 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.59 -2.98 48.62 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.252 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -89.54 3.75 51.49 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.8 129.17 44.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.07 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 87.0 p . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.07 -179.878 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 141' ' ' PRO . 97.1 mttt -83.55 -34.75 0.6 Allowed Pre-proline 0 CA--C 1.554 1.114 0 CA-C-O 118.7 -0.667 . . . . 0.0 111.882 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 140' ' ' LYS . 25.1 Cg_endo -92.65 179.6 1.19 Allowed 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 122.331 2.02 . . . . 0.0 112.177 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -65.83 -132.17 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.367 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 52.16 65.83 1.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 119.162 0.892 . . . . 0.0 110.467 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -126.29 121.42 32.58 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.82 130.05 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.37 109.52 17.45 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.727 0.239 . . . . 0.0 110.805 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.16 153.11 42.01 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.73 -40.39 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.51 -25.79 16.07 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.517 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -118.38 126.88 53.02 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.514 0.509 . . . . 0.0 111.623 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.6 119.2 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 145.64 -177.63 23.91 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.88 154.24 51.48 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 122.531 2.154 . . . . 0.0 112.909 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -64.75 126.78 29.02 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.146 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -75.94 -1.34 25.08 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.965 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -95.23 132.25 40.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.061 0.544 . . . . 0.0 111.131 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -155.95 -8.69 0.11 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -114.55 148.01 38.62 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.57 118.3 6.18 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.9 t -108.4 110.2 21.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.805 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.72 -11.8 60.26 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 120.878 1.672 . . . . 0.0 110.839 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -106.16 31.73 4.92 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.52 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -72.47 115.29 11.56 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.699 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -100.75 99.04 9.52 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 165.77 -179.72 39.87 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.02 133.51 19.88 Favored 'Trans proline' 0 N--CA 1.51 2.446 0 C-N-CA 122.172 1.915 . . . . 0.0 111.738 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -97.31 141.59 30.22 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -142.69 15.0 1.96 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.64 0.655 . . . . 0.0 112.083 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -94.52 134.7 36.79 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 118.049 0.386 . . . . 0.0 111.489 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -58.94 -30.56 67.96 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.904 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.84 -3.08 39.74 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.142 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -87.66 4.6 43.35 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.042 0.537 . . . . 0.0 109.646 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.71 130.43 43.94 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.005 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 54.9 p . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 117.96 -1.019 . . . . 0.0 111.667 -179.567 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -53.78 112.41 3.73 Favored Pre-proline 0 CA--C 1.56 1.341 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.96 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -87.12 172.16 6.32 Favored 'Trans proline' 0 N--CA 1.505 2.164 0 C-N-CA 122.111 1.874 . . . . 0.0 111.268 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -71.45 -136.0 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 53.96 65.34 1.54 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.625 0.37 . . . . 0.0 111.3 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -126.19 118.72 25.77 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.63 130.28 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.46 109.88 17.88 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 121.098 0.475 . . . . 0.0 111.477 -179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.74 153.2 41.24 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.8 m -55.47 -39.97 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.09 -25.57 15.83 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.835 0.289 . . . . 0.0 111.494 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -118.93 128.01 54.02 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.594 0.559 . . . . 0.0 111.671 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.6 119.32 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 148.96 -175.16 28.34 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.69 156.77 62.67 Favored 'Trans proline' 0 N--CA 1.508 2.328 0 C-N-CA 122.595 2.196 . . . . 0.0 112.268 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -64.84 125.08 23.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.218 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -77.62 -0.87 28.2 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.906 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -93.67 133.85 36.59 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.822 0.449 . . . . 0.0 110.433 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -155.53 -11.41 0.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -114.0 147.81 38.0 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.443 ' C ' HD21 ' A' ' 159' ' ' ASN . 0.2 OUTLIER -142.72 116.04 9.01 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.44 ' N ' HD21 ' A' ' 159' ' ' ASN . 46.9 t -108.87 104.82 14.14 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.206 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.16 -11.5 60.31 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 121.123 1.783 . . . . 0.0 110.343 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -105.54 32.27 4.41 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.33 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -71.14 119.68 15.61 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -103.48 98.9 8.72 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 161.85 178.97 36.21 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -73.68 134.44 20.23 Favored 'Trans proline' 0 N--CA 1.511 2.524 0 C-N-CA 122.385 2.057 . . . . 0.0 112.088 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -97.6 142.11 29.82 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.007 0.923 . . . . 0.0 108.887 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.27 15.4 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 118.676 0.671 . . . . 0.0 111.82 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -93.9 133.64 37.1 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 120.753 0.311 . . . . 0.0 111.521 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -58.97 -30.43 67.92 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.952 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.78 -3.48 41.58 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.015 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -89.84 4.35 50.12 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.997 0.519 . . . . 0.0 109.776 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -95.09 132.12 40.34 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.269 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 96.9 p . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.781 -179.729 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.32 130.68 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -116.28 110.31 18.57 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.851 0.358 . . . . 0.0 111.283 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.19 152.52 44.4 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.55 -40.15 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.23 -25.84 15.65 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.393 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -118.51 126.37 51.86 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.505 0.503 . . . . 0.0 111.261 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.1 t -132.64 119.31 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 148.9 -174.3 28.57 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.8 155.39 68.82 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 C-N-CA 122.614 2.21 . . . . 0.0 112.293 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -64.58 127.65 32.42 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.2 1.0 . . . . 0.0 112.459 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -78.36 -1.08 31.6 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.076 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -92.73 132.18 37.16 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.788 0.435 . . . . 0.0 110.473 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.414 ' H ' ' H ' ' A' ' 158' ' ' PHE . 39.3 ttm180 -155.41 -13.03 0.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.227 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.414 ' H ' ' H ' ' A' ' 157' ' ' ARG . 10.7 t80 . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.52 130.17 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.34 109.5 17.44 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.65 154.65 39.06 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.18 -37.62 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -176.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.42 -25.78 14.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.599 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -118.65 128.73 54.8 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.695 0.622 . . . . 0.0 111.744 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 54.8 t -134.46 119.22 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.65 -177.58 25.83 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.85 153.53 56.25 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 122.383 2.056 . . . . 0.0 113.035 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -65.48 126.04 27.06 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.665 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -77.11 -1.06 27.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.048 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -94.69 133.33 38.48 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.046 0.539 . . . . 0.0 110.769 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.415 ' H ' ' H ' ' A' ' 158' ' ' PHE . 27.7 ttp-105 -155.61 -10.45 0.11 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.383 0.673 . . . . 0.0 109.262 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.415 ' H ' ' H ' ' A' ' 157' ' ' ARG . 8.3 t80 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.69 131.63 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -116.41 109.06 16.82 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.828 0.347 . . . . 0.0 110.884 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.99 153.81 40.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.6 m -55.32 -38.26 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.62 -25.72 14.63 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.416 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -118.88 127.77 53.82 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.602 0.564 . . . . 0.0 111.88 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.22 119.32 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 146.32 -176.62 25.15 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.06 151.7 70.58 Favored 'Trans proline' 0 N--CA 1.507 2.317 0 C-N-CA 122.417 2.078 . . . . 0.0 112.854 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -64.38 129.48 40.07 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.743 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -78.99 -1.1 33.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.872 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -95.55 131.77 41.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.228 0.611 . . . . 0.0 110.681 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.416 ' H ' ' H ' ' A' ' 158' ' ' PHE . 16.0 ptm180 -155.74 -7.57 0.12 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.257 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.416 ' H ' ' H ' ' A' ' 157' ' ' ARG . 3.8 t80 . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 38.1 t-105 . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.58 129.9 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -116.19 108.31 15.98 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 117.672 0.215 . . . . 0.0 110.677 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.21 152.1 41.59 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.3 m -55.56 -40.08 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.7 -25.55 16.06 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.818 0.281 . . . . 0.0 111.748 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -118.62 126.18 51.38 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.575 0.547 . . . . 0.0 111.375 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 52.7 t -130.78 119.33 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 144.06 -177.12 22.94 Favored Glycine 0 CA--C 1.538 1.499 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.4 153.94 50.63 Favored 'Trans proline' 0 N--CA 1.513 2.656 0 C-N-CA 122.891 2.394 . . . . 0.0 113.599 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -65.2 128.31 35.28 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.364 1.065 . . . . 0.0 112.41 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -81.0 -1.0 42.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -92.94 129.44 38.85 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.914 0.486 . . . . 0.0 110.857 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.44 ' H ' ' H ' ' A' ' 158' ' ' PHE . 34.1 ptt180 -155.95 -9.53 0.11 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.377 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.44 ' H ' ' H ' ' A' ' 157' ' ' ARG . 9.2 t80 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.44 129.19 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.46 108.95 16.66 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.82 153.61 40.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.3 p -55.31 -39.27 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.77 -25.74 14.95 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.972 0.351 . . . . 0.0 111.539 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -118.21 126.62 52.56 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.579 0.549 . . . . 0.0 111.576 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.66 119.57 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.88 -175.88 26.99 Favored Glycine 0 CA--C 1.536 1.349 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.1 157.07 63.52 Favored 'Trans proline' 0 N--CA 1.508 2.34 0 C-N-CA 122.546 2.164 . . . . 0.0 112.431 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -64.96 126.18 27.2 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.299 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -77.82 -1.02 29.5 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.027 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -92.89 129.87 38.66 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.881 0.472 . . . . 0.0 110.576 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.409 ' H ' ' H ' ' A' ' 158' ' ' PHE . 89.9 mtt-85 -150.36 -11.91 0.25 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.409 ' H ' ' H ' ' A' ' 157' ' ' ARG . 9.4 t80 . . . . . 0 N--CA 1.472 0.665 0 C-N-CA 123.868 0.867 . . . . 0.0 108.817 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.84 132.23 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -116.25 109.22 17.11 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 120.541 0.21 . . . . 0.0 110.952 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.03 153.19 40.18 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.33 -38.95 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.14 -25.53 14.88 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.866 0.303 . . . . 0.0 111.455 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -118.05 126.39 52.2 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.665 0.603 . . . . 0.0 111.551 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.6 t -132.3 119.26 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.73 -175.08 27.24 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.26 154.84 72.93 Favored 'Trans proline' 0 N--CA 1.506 2.243 0 C-N-CA 122.411 2.074 . . . . 0.0 112.36 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -64.36 128.56 36.3 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.338 1.055 . . . . 0.0 112.271 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -80.0 -1.03 37.88 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.778 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -94.59 131.64 40.15 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.059 0.544 . . . . 0.0 110.468 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.418 ' H ' ' H ' ' A' ' 158' ' ' PHE . 38.6 ptt180 -155.8 -9.84 0.11 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.745 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.418 ' H ' ' H ' ' A' ' 157' ' ' ARG . 7.0 t80 . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.77 127.95 75.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.903 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -116.63 110.98 19.22 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 120.952 0.406 . . . . 0.0 110.486 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.41 156.22 37.49 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.9 m -55.47 -40.43 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.68 -25.56 15.51 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.337 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -118.64 128.34 54.44 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.737 0.648 . . . . 0.0 111.872 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.73 119.33 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.7 -174.95 30.69 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 156.45 65.56 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 122.425 2.084 . . . . 0.0 112.124 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.81 123.58 19.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.921 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -76.13 -0.98 23.95 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.826 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -93.39 134.89 35.16 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.997 0.519 . . . . 0.0 109.945 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.411 ' H ' ' H ' ' A' ' 158' ' ' PHE . 40.9 ttm180 -154.99 -14.9 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.947 0.499 . . . . 0.0 109.892 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.411 ' H ' ' H ' ' A' ' 157' ' ' ARG . 8.3 t80 . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.1 129.34 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -116.5 109.88 17.86 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.79 154.99 38.76 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.0 m -55.81 -39.63 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.2 -25.48 15.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.519 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -118.45 128.15 54.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.559 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.3 t -132.57 119.33 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 150.97 -175.36 29.97 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.49 160.59 48.99 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 122.457 2.105 . . . . 0.0 112.315 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.77 125.86 26.11 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.613 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -81.37 -0.73 42.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.064 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -96.88 107.39 19.89 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.274 0.629 . . . . 0.0 110.989 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 34.0 mtm105 -131.15 -6.04 3.87 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.119 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.674 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.82 130.05 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.37 109.52 17.45 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.727 0.239 . . . . 0.0 110.805 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.16 153.11 42.01 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.73 -40.39 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.51 -25.79 16.07 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.517 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -118.38 126.88 53.02 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.514 0.509 . . . . 0.0 111.623 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.6 119.2 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 145.64 -177.63 23.91 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.88 154.24 51.48 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 122.531 2.154 . . . . 0.0 112.909 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -64.75 126.78 29.02 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.146 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -75.94 -1.34 25.08 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.965 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -95.23 132.25 40.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.061 0.544 . . . . 0.0 111.131 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.43 ' H ' ' H ' ' A' ' 158' ' ' PHE . 11.6 ptp180 -155.95 -8.69 0.11 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.43 ' H ' ' H ' ' A' ' 157' ' ' ARG . 4.8 t80 . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.63 130.28 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 146' ' ' GLU . 0.5 OUTLIER -116.46 109.88 17.88 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 121.098 0.475 . . . . 0.0 111.477 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.74 153.2 41.24 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.8 m -55.47 -39.97 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.09 -25.57 15.83 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.835 0.289 . . . . 0.0 111.494 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -118.93 128.01 54.02 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.594 0.559 . . . . 0.0 111.671 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.6 119.32 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 148.96 -175.16 28.34 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.69 156.77 62.67 Favored 'Trans proline' 0 N--CA 1.508 2.328 0 C-N-CA 122.595 2.196 . . . . 0.0 112.268 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -64.84 125.08 23.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.218 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -77.62 -0.87 28.2 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.906 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -93.67 133.85 36.59 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.822 0.449 . . . . 0.0 110.433 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ARG . . . . . 0.424 ' H ' ' H ' ' A' ' 158' ' ' PHE . 76.5 ttt180 -155.53 -11.41 0.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.424 ' H ' ' H ' ' A' ' 157' ' ' ARG . 5.5 t80 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -161.71 75.14 2.37 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -86.33 179.61 3.49 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 122.647 2.232 . . . . 0.0 111.034 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -70.55 -136.04 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 54.15 62.65 2.49 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.598 0.359 . . . . 0.0 111.253 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -126.4 119.25 26.81 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.32 130.68 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -116.28 110.31 18.57 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.851 0.358 . . . . 0.0 111.283 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.19 152.52 44.4 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.55 -40.15 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.23 -25.84 15.65 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.393 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -118.51 126.37 51.86 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.505 0.503 . . . . 0.0 111.261 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.1 t -132.64 119.31 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 148.9 -174.3 28.57 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.8 155.39 68.82 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 C-N-CA 122.614 2.21 . . . . 0.0 112.293 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -64.58 127.65 32.42 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.2 1.0 . . . . 0.0 112.459 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -78.36 -1.08 31.6 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.076 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -92.73 132.18 37.16 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.788 0.435 . . . . 0.0 110.473 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.414 ' H ' ' H ' ' A' ' 158' ' ' PHE . 39.3 ttm180 -155.41 -13.03 0.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.227 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.414 ' H ' ' H ' ' A' ' 157' ' ' ARG . 10.7 t80 -114.46 148.19 38.18 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -146.79 117.42 7.55 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 45.2 t -108.51 109.04 20.2 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.249 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.69 -12.01 60.32 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 121.063 1.756 . . . . 0.0 110.586 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -105.57 32.4 4.33 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.328 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -70.54 120.1 15.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.696 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -103.78 99.13 8.91 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 161.28 -179.52 36.66 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.23 134.62 21.33 Favored 'Trans proline' 0 N--CA 1.511 2.525 0 C-N-CA 122.454 2.103 . . . . 0.0 112.122 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -96.18 141.45 29.53 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.9 0.88 . . . . 0.0 108.639 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.12 14.55 1.67 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.634 0.652 . . . . 0.0 111.938 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -94.46 134.88 36.51 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 118.092 0.406 . . . . 0.0 111.59 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -58.89 -31.65 68.79 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.659 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.41 -3.22 35.85 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.037 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -87.59 4.2 44.67 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.18 131.67 43.7 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.424 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 117.969 -1.015 . . . . 0.0 111.009 -179.931 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.53 119.5 57.44 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.56 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -78.64 -124.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.508 2.371 0 C-N-CA 121.706 1.604 . . . . 0.0 111.235 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -146.87 47.6 1.16 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -124.82 43.81 2.94 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.462 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -114.39 119.99 38.82 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.96 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.52 130.17 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.34 109.5 17.44 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.65 154.65 39.06 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.18 -37.62 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -176.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.42 -25.78 14.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.599 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -118.65 128.73 54.8 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.695 0.622 . . . . 0.0 111.744 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 54.8 t -134.46 119.22 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.65 -177.58 25.83 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.85 153.53 56.25 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 122.383 2.056 . . . . 0.0 113.035 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -65.48 126.04 27.06 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.665 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -77.11 -1.06 27.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.048 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -94.69 133.33 38.48 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.046 0.539 . . . . 0.0 110.769 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.415 ' H ' ' H ' ' A' ' 158' ' ' PHE . 27.7 ttp-105 -155.61 -10.45 0.11 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.383 0.673 . . . . 0.0 109.262 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.415 ' H ' ' H ' ' A' ' 157' ' ' ARG . 8.3 t80 -114.16 148.06 37.86 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 64.0 t-20 -141.72 116.83 9.99 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 47.7 t -108.94 104.61 13.88 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.242 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.6 -11.73 60.27 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 121.177 1.808 . . . . 0.0 110.686 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -105.73 31.96 4.66 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.699 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -70.45 119.04 14.03 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -103.57 99.18 8.99 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 161.93 178.37 35.77 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.45 134.2 20.28 Favored 'Trans proline' 0 N--CA 1.508 2.378 0 C-N-CA 122.304 2.003 . . . . 0.0 111.896 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -97.41 141.54 30.36 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -143.86 15.12 1.74 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.362 0.528 . . . . 0.0 111.734 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.16 133.55 37.55 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.035 0.38 . . . . 0.0 111.632 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -58.3 -30.44 66.66 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.635 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.25 -3.21 38.62 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.157 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -90.19 3.92 52.06 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.45 133.06 42.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.78 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.815 179.581 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -165.24 59.62 0.65 Allowed Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.422 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -81.87 160.47 18.63 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.104 1.869 . . . . 0.0 110.873 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -69.73 -138.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.24 72.51 0.42 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.808 0.443 . . . . 0.0 111.359 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -126.2 120.16 29.33 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.69 131.63 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -116.41 109.06 16.82 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.828 0.347 . . . . 0.0 110.884 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.99 153.81 40.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.6 m -55.32 -38.26 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.62 -25.72 14.63 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.416 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -118.88 127.77 53.82 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.602 0.564 . . . . 0.0 111.88 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.22 119.32 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 146.32 -176.62 25.15 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.06 151.7 70.58 Favored 'Trans proline' 0 N--CA 1.507 2.317 0 C-N-CA 122.417 2.078 . . . . 0.0 112.854 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -64.38 129.48 40.07 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.743 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -78.99 -1.1 33.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.872 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -95.55 131.77 41.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.228 0.611 . . . . 0.0 110.681 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.416 ' H ' ' H ' ' A' ' 158' ' ' PHE . 16.0 ptm180 -155.74 -7.57 0.12 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.257 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.416 ' H ' ' H ' ' A' ' 157' ' ' ARG . 3.8 t80 -114.04 147.98 37.79 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -140.68 116.39 10.26 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 43.1 t -108.84 104.79 14.11 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.3 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.73 -11.85 60.27 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 121.185 1.811 . . . . 0.0 110.681 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -106.7 32.43 4.54 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.742 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -67.81 121.69 16.53 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -103.85 99.27 9.04 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 154.57 169.53 19.37 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.52 133.84 57.19 Favored 'Trans proline' 0 N--CA 1.514 2.728 0 C-N-CA 122.193 1.929 . . . . 0.0 112.735 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -97.95 142.1 30.1 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.126 0.97 . . . . 0.0 108.606 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 14.63 2.22 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.735 0.698 . . . . 0.0 112.326 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -93.48 133.7 36.51 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.179 0.445 . . . . 0.0 111.287 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -57.57 -30.78 65.53 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.438 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.59 -2.95 38.33 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.208 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -87.31 4.4 43.0 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.921 0.488 . . . . 0.0 110.151 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -95.78 129.64 42.95 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 118.175 -0.916 . . . . 0.0 110.363 -179.697 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -165.39 67.0 1.17 Allowed Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -81.73 -121.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.133 0 C-N-CA 122.57 2.18 . . . . 0.0 112.791 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -84.44 127.91 34.28 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -177.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 63.24 45.49 5.02 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.215 1.006 . . . . 0.0 112.653 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 38.1 t-105 -127.18 117.76 22.97 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.538 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.58 129.9 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -116.19 108.31 15.98 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 117.672 0.215 . . . . 0.0 110.677 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.21 152.1 41.59 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.3 m -55.56 -40.08 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.7 -25.55 16.06 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.818 0.281 . . . . 0.0 111.748 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -118.62 126.18 51.38 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.575 0.547 . . . . 0.0 111.375 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 52.7 t -130.78 119.33 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 144.06 -177.12 22.94 Favored Glycine 0 CA--C 1.538 1.499 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.4 153.94 50.63 Favored 'Trans proline' 0 N--CA 1.513 2.656 0 C-N-CA 122.891 2.394 . . . . 0.0 113.599 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -65.2 128.31 35.28 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.364 1.065 . . . . 0.0 112.41 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -81.0 -1.0 42.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -92.94 129.44 38.85 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.914 0.486 . . . . 0.0 110.857 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.44 ' H ' ' H ' ' A' ' 158' ' ' PHE . 34.1 ptt180 -155.95 -9.53 0.11 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.377 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.44 ' H ' ' H ' ' A' ' 157' ' ' ARG . 9.2 t80 -114.83 148.05 39.03 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -146.05 117.96 8.21 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.8 t -108.56 105.81 15.6 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.286 -0.864 . . . . 0.0 109.733 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.79 -11.83 60.51 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.806 1.639 . . . . 0.0 110.971 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -104.45 30.26 5.47 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.056 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -70.6 118.45 13.41 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.792 -0.186 . . . . 0.0 111.319 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -103.55 99.22 9.03 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 158.37 169.51 21.96 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.49 133.53 57.5 Favored 'Trans proline' 0 N--CA 1.516 2.851 0 C-N-CA 122.107 1.871 . . . . 0.0 113.128 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -96.25 141.91 29.03 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.095 0.958 . . . . 0.0 108.604 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.08 14.24 2.24 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 118.607 0.64 . . . . 0.0 112.101 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -96.05 135.36 37.94 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.054 0.454 . . . . 0.0 111.753 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -59.55 -31.06 69.07 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.818 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.55 -3.25 39.7 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.113 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -86.85 4.37 41.55 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.27 130.35 43.38 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.789 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.986 -179.638 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 53.64 76.82 0.49 Allowed Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.438 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.31 171.8 0.52 Allowed 'Trans proline' 0 N--CA 1.513 2.668 0 C-N-CA 122.236 1.957 . . . . 0.0 112.44 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -69.6 125.22 26.06 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.752 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 61.12 44.16 10.4 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.422 0.689 . . . . 0.0 111.68 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -126.66 119.78 27.86 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 123.397 0.436 . . . . 0.0 112.089 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.44 129.19 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.46 108.95 16.66 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.82 153.61 40.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.3 p -55.31 -39.27 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.77 -25.74 14.95 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.972 0.351 . . . . 0.0 111.539 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -118.21 126.62 52.56 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.579 0.549 . . . . 0.0 111.576 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.66 119.57 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.88 -175.88 26.99 Favored Glycine 0 CA--C 1.536 1.349 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.1 157.07 63.52 Favored 'Trans proline' 0 N--CA 1.508 2.34 0 C-N-CA 122.546 2.164 . . . . 0.0 112.431 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -64.96 126.18 27.2 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.299 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -77.82 -1.02 29.5 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.027 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -92.89 129.87 38.66 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.881 0.472 . . . . 0.0 110.576 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.409 ' H ' ' H ' ' A' ' 158' ' ' PHE . 89.9 mtt-85 -150.36 -11.91 0.25 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.409 ' H ' ' H ' ' A' ' 157' ' ' ARG . 9.4 t80 -114.76 148.0 38.97 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.868 0.867 . . . . 0.0 108.817 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -145.85 117.27 7.98 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.7 t -108.76 107.29 17.68 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.188 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.29 -11.77 60.36 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 121.142 1.792 . . . . 0.0 110.224 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -105.23 32.7 4.07 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.471 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -69.93 120.1 15.15 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.744 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -103.89 99.07 8.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 159.49 -179.19 35.25 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -73.23 134.31 20.82 Favored 'Trans proline' 0 N--CA 1.509 2.424 0 C-N-CA 122.438 2.092 . . . . 0.0 111.928 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -96.77 141.91 29.42 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.02 15.35 1.9 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 118.557 0.617 . . . . 0.0 112.141 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -95.17 134.86 37.44 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.09 0.405 . . . . 0.0 111.452 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -58.57 -32.05 68.57 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.766 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.39 -3.28 36.15 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.227 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -89.58 4.35 49.64 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.841 0.456 . . . . 0.0 109.833 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.46 133.6 40.68 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.52 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 118.264 -0.874 . . . . 0.0 109.893 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -69.21 148.69 97.55 Favored Pre-proline 0 CA--C 1.555 1.137 0 CA-C-O 118.867 -0.587 . . . . 0.0 110.347 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.45 170.24 18.72 Favored 'Trans proline' 0 N--CA 1.507 2.316 0 C-N-CA 121.808 1.672 . . . . 0.0 110.563 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -72.69 -134.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 52.03 66.2 1.27 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.563 0.345 . . . . 0.0 110.654 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -126.68 119.72 27.69 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.84 132.23 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -116.25 109.22 17.11 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 120.541 0.21 . . . . 0.0 110.952 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.03 153.19 40.18 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.33 -38.95 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.14 -25.53 14.88 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.866 0.303 . . . . 0.0 111.455 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -118.05 126.39 52.2 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.665 0.603 . . . . 0.0 111.551 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.6 t -132.3 119.26 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.73 -175.08 27.24 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.26 154.84 72.93 Favored 'Trans proline' 0 N--CA 1.506 2.243 0 C-N-CA 122.411 2.074 . . . . 0.0 112.36 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -64.36 128.56 36.3 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.338 1.055 . . . . 0.0 112.271 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -80.0 -1.03 37.88 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.778 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -94.59 131.64 40.15 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.059 0.544 . . . . 0.0 110.468 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.418 ' H ' ' H ' ' A' ' 158' ' ' PHE . 38.6 ptt180 -155.8 -9.84 0.11 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.745 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.418 ' H ' ' H ' ' A' ' 157' ' ' ARG . 7.0 t80 -114.66 112.77 23.4 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -103.93 116.61 32.57 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.5 t -108.85 103.83 12.97 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 118.277 -0.868 . . . . 0.0 109.917 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.86 -12.05 60.28 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 120.829 1.65 . . . . 0.0 110.497 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -105.59 31.19 5.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.603 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -73.62 119.3 17.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.978 -0.101 . . . . 0.0 110.952 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -103.76 100.33 10.14 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.173 0.511 . . . . 0.0 110.2 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 160.55 179.47 35.34 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.79 134.62 32.99 Favored 'Trans proline' 0 N--CA 1.516 2.807 0 C-N-CA 122.152 1.901 . . . . 0.0 112.556 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.32 142.1 27.7 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.56 11.25 2.72 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 118.596 0.635 . . . . 0.0 111.447 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -93.83 134.08 36.57 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 120.639 0.257 . . . . 0.0 111.081 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -57.35 -32.1 66.4 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.171 0.588 . . . . 0.0 112.151 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.92 -3.11 33.61 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.33 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.56 4.74 38.8 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.22 0.608 . . . . 0.0 110.164 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -95.96 130.37 42.96 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 118.041 -0.98 . . . . 0.0 111.667 -179.292 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.4 p . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 56.13 60.7 8.17 Favored Pre-proline 0 CA--C 1.555 1.144 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.271 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -88.32 -174.47 1.12 Allowed 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.636 2.224 . . . . 0.0 111.129 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -66.25 -137.62 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.178 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 55.95 53.13 9.59 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 119.092 0.86 . . . . 0.0 110.565 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 -117.26 122.79 44.95 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.77 127.95 75.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.903 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -116.63 110.98 19.22 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 120.952 0.406 . . . . 0.0 110.486 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.41 156.22 37.49 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.9 m -55.47 -40.43 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.68 -25.56 15.51 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.337 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -118.64 128.34 54.44 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.737 0.648 . . . . 0.0 111.872 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.73 119.33 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.7 -174.95 30.69 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 156.45 65.56 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 122.425 2.084 . . . . 0.0 112.124 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.81 123.58 19.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.921 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -76.13 -0.98 23.95 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.826 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -93.39 134.89 35.16 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.997 0.519 . . . . 0.0 109.945 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.411 ' H ' ' H ' ' A' ' 158' ' ' PHE . 40.9 ttm180 -154.99 -14.9 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.947 0.499 . . . . 0.0 109.892 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.411 ' H ' ' H ' ' A' ' 157' ' ' ARG . 8.3 t80 -114.4 147.87 38.56 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -137.72 116.42 12.19 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.4 t -109.05 104.06 13.2 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.391 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.95 -11.84 60.21 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 121.054 1.752 . . . . 0.0 110.909 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -104.93 30.57 5.42 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.141 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -74.27 117.97 16.69 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.666 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -102.9 99.27 9.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 166.51 -179.24 40.58 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.89 132.48 18.48 Favored 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 121.963 1.775 . . . . 0.0 111.414 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -97.69 142.05 29.96 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.062 0.945 . . . . 0.0 108.679 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.13 16.91 1.55 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.453 0.57 . . . . 0.0 111.96 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -97.75 137.49 36.55 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 118.095 0.407 . . . . 0.0 111.611 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -62.04 -28.87 69.9 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.35 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.52 -2.93 48.13 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.81 3.95 51.3 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -98.31 133.94 42.02 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.586 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.627 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 95.4 p . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.53 ' H ' ' CD ' ' A' ' 141' ' ' PRO . 64.3 tttm -163.34 -42.75 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.558 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.53 ' CD ' ' H ' ' A' ' 140' ' ' LYS . 13.1 Cg_endo -94.75 -112.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 122.39 2.06 . . . . 0.0 111.819 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -135.48 -130.83 0.15 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.852 0.861 . . . . 0.0 108.816 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 57.27 47.56 16.64 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 118.425 0.557 . . . . 0.0 109.591 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -119.71 119.9 35.01 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.1 129.34 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -116.5 109.88 17.86 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.79 154.99 38.76 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.0 m -55.81 -39.63 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.2 -25.48 15.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.519 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -118.45 128.15 54.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.559 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.3 t -132.57 119.33 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 150.97 -175.36 29.97 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.49 160.59 48.99 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 122.457 2.105 . . . . 0.0 112.315 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.77 125.86 26.11 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.613 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -81.37 -0.73 42.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.064 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -96.88 107.39 19.89 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.274 0.629 . . . . 0.0 110.989 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 34.0 mtm105 -131.15 -6.04 3.87 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.119 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -114.51 147.88 38.73 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -142.82 118.65 10.54 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.8 t -108.5 105.9 15.76 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 118.21 -0.9 . . . . 0.0 109.09 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.73 -11.56 60.2 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 120.885 1.675 . . . . 0.0 111.138 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -108.63 30.67 6.26 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.992 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -65.76 117.57 8.36 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -176.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -102.42 99.28 9.32 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 161.75 -179.92 36.82 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.4 132.8 18.18 Favored 'Trans proline' 0 N--CA 1.508 2.381 0 C-N-CA 122.329 2.02 . . . . 0.0 111.781 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -94.6 140.8 29.37 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.58 14.2 2.15 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.334 0.515 . . . . 0.0 111.659 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -93.87 131.38 39.33 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 118.015 0.37 . . . . 0.0 110.787 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -58.31 -27.72 64.36 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.655 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.59 -2.98 48.62 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.252 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -89.54 3.75 51.49 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.8 129.17 44.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.07 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 87.0 p . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.07 -179.878 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 141' ' ' PRO . 97.1 mttt -83.55 -34.75 0.6 Allowed Pre-proline 0 CA--C 1.554 1.114 0 CA-C-O 118.7 -0.667 . . . . 0.0 111.882 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 140' ' ' LYS . 25.1 Cg_endo -92.65 179.6 1.19 Allowed 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 122.331 2.02 . . . . 0.0 112.177 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -65.83 -132.17 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.367 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 52.16 65.83 1.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 119.162 0.892 . . . . 0.0 110.467 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -126.29 121.42 32.58 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.82 130.05 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.37 109.52 17.45 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.727 0.239 . . . . 0.0 110.805 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.16 153.11 42.01 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.73 -40.39 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.51 -25.79 16.07 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.517 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -118.38 126.88 53.02 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.514 0.509 . . . . 0.0 111.623 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.6 119.2 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 145.64 -177.63 23.91 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.88 154.24 51.48 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 122.531 2.154 . . . . 0.0 112.909 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -64.75 126.78 29.02 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.146 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -75.94 -1.34 25.08 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.965 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -95.23 132.25 40.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.061 0.544 . . . . 0.0 111.131 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.43 ' H ' ' H ' ' A' ' 158' ' ' PHE . 11.6 ptp180 -155.95 -8.69 0.11 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.43 ' H ' ' H ' ' A' ' 157' ' ' ARG . 4.8 t80 -114.55 148.01 38.62 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -150.57 118.3 6.18 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.9 t -108.4 110.2 21.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.805 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.72 -11.8 60.26 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 120.878 1.672 . . . . 0.0 110.839 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -106.16 31.73 4.92 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.52 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -72.47 115.29 11.56 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.699 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -100.75 99.04 9.52 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 165.77 -179.72 39.87 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.02 133.51 19.88 Favored 'Trans proline' 0 N--CA 1.51 2.446 0 C-N-CA 122.172 1.915 . . . . 0.0 111.738 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -97.31 141.59 30.22 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -142.69 15.0 1.96 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.64 0.655 . . . . 0.0 112.083 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -94.52 134.7 36.79 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 118.049 0.386 . . . . 0.0 111.489 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -58.94 -30.56 67.96 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.904 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.84 -3.08 39.74 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.142 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -87.66 4.6 43.35 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.042 0.537 . . . . 0.0 109.646 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.71 130.43 43.94 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.005 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 54.9 p . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 117.96 -1.019 . . . . 0.0 111.667 -179.567 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -53.78 112.41 3.73 Favored Pre-proline 0 CA--C 1.56 1.341 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.96 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -87.12 172.16 6.32 Favored 'Trans proline' 0 N--CA 1.505 2.164 0 C-N-CA 122.111 1.874 . . . . 0.0 111.268 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -71.45 -136.0 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 53.96 65.34 1.54 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.625 0.37 . . . . 0.0 111.3 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -126.19 118.72 25.77 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.63 130.28 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 146' ' ' GLU . 0.5 OUTLIER -116.46 109.88 17.88 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 121.098 0.475 . . . . 0.0 111.477 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.74 153.2 41.24 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.8 m -55.47 -39.97 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.09 -25.57 15.83 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.835 0.289 . . . . 0.0 111.494 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -118.93 128.01 54.02 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.594 0.559 . . . . 0.0 111.671 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.6 119.32 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 148.96 -175.16 28.34 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.69 156.77 62.67 Favored 'Trans proline' 0 N--CA 1.508 2.328 0 C-N-CA 122.595 2.196 . . . . 0.0 112.268 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -64.84 125.08 23.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.218 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -77.62 -0.87 28.2 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.906 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -93.67 133.85 36.59 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.822 0.449 . . . . 0.0 110.433 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . 0.424 ' H ' ' H ' ' A' ' 158' ' ' PHE . 76.5 ttt180 -155.53 -11.41 0.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.424 ' H ' ' H ' ' A' ' 157' ' ' ARG . 5.5 t80 -114.0 147.81 38.0 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -142.72 116.04 9.01 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.9 t -108.87 104.82 14.14 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.206 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.16 -11.5 60.31 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 121.123 1.783 . . . . 0.0 110.343 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -105.54 32.27 4.41 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.33 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -71.14 119.68 15.61 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -103.48 98.9 8.72 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 161.85 178.97 36.21 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -73.68 134.44 20.23 Favored 'Trans proline' 0 N--CA 1.511 2.524 0 C-N-CA 122.385 2.057 . . . . 0.0 112.088 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -97.6 142.11 29.82 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.007 0.923 . . . . 0.0 108.887 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.27 15.4 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 118.676 0.671 . . . . 0.0 111.82 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -93.9 133.64 37.1 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 120.753 0.311 . . . . 0.0 111.521 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -58.97 -30.43 67.92 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.952 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.78 -3.48 41.58 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.015 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -89.84 4.35 50.12 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.997 0.519 . . . . 0.0 109.776 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -95.09 132.12 40.34 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.269 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 96.9 p . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.781 -179.729 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 . . . . . 0 N--CA 1.483 1.192 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.32 130.68 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -116.28 110.31 18.57 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.851 0.358 . . . . 0.0 111.283 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.19 152.52 44.4 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.55 -40.15 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.23 -25.84 15.65 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.393 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -118.51 126.37 51.86 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.505 0.503 . . . . 0.0 111.261 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.1 t -132.64 119.31 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 148.9 -174.3 28.57 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.8 155.39 68.82 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 C-N-CA 122.614 2.21 . . . . 0.0 112.293 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -64.58 127.65 32.42 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.2 1.0 . . . . 0.0 112.459 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -78.36 -1.08 31.6 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.076 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -92.73 132.18 37.16 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.788 0.435 . . . . 0.0 110.473 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.414 ' H ' ' H ' ' A' ' 158' ' ' PHE . 39.3 ttm180 -155.41 -13.03 0.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.227 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.414 ' H ' ' H ' ' A' ' 157' ' ' ARG . 10.7 t80 . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.52 130.17 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.34 109.5 17.44 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.65 154.65 39.06 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.18 -37.62 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -176.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.42 -25.78 14.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.599 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -118.65 128.73 54.8 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.695 0.622 . . . . 0.0 111.744 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 54.8 t -134.46 119.22 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.65 -177.58 25.83 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.85 153.53 56.25 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 122.383 2.056 . . . . 0.0 113.035 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -65.48 126.04 27.06 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.665 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -77.11 -1.06 27.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.048 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -94.69 133.33 38.48 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.046 0.539 . . . . 0.0 110.769 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.415 ' H ' ' H ' ' A' ' 158' ' ' PHE . 27.7 ttp-105 -155.61 -10.45 0.11 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.383 0.673 . . . . 0.0 109.262 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.415 ' H ' ' H ' ' A' ' 157' ' ' ARG . 8.3 t80 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.69 131.63 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -116.41 109.06 16.82 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.828 0.347 . . . . 0.0 110.884 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.99 153.81 40.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.6 m -55.32 -38.26 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.62 -25.72 14.63 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.416 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -118.88 127.77 53.82 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.602 0.564 . . . . 0.0 111.88 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.22 119.32 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 146.32 -176.62 25.15 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.06 151.7 70.58 Favored 'Trans proline' 0 N--CA 1.507 2.317 0 C-N-CA 122.417 2.078 . . . . 0.0 112.854 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -64.38 129.48 40.07 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.743 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -78.99 -1.1 33.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.872 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -95.55 131.77 41.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.228 0.611 . . . . 0.0 110.681 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.416 ' H ' ' H ' ' A' ' 158' ' ' PHE . 16.0 ptm180 -155.74 -7.57 0.12 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.257 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.416 ' H ' ' H ' ' A' ' 157' ' ' ARG . 3.8 t80 . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 38.1 t-105 . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 111.538 0.199 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.58 129.9 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -116.19 108.31 15.98 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 117.672 0.215 . . . . 0.0 110.677 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.21 152.1 41.59 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.3 m -55.56 -40.08 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.7 -25.55 16.06 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.818 0.281 . . . . 0.0 111.748 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -118.62 126.18 51.38 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.575 0.547 . . . . 0.0 111.375 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 52.7 t -130.78 119.33 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 144.06 -177.12 22.94 Favored Glycine 0 CA--C 1.538 1.499 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.4 153.94 50.63 Favored 'Trans proline' 0 N--CA 1.513 2.656 0 C-N-CA 122.891 2.394 . . . . 0.0 113.599 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -65.2 128.31 35.28 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.364 1.065 . . . . 0.0 112.41 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -81.0 -1.0 42.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -92.94 129.44 38.85 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.914 0.486 . . . . 0.0 110.857 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.44 ' H ' ' H ' ' A' ' 158' ' ' PHE . 34.1 ptt180 -155.95 -9.53 0.11 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.377 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.44 ' H ' ' H ' ' A' ' 157' ' ' ARG . 9.2 t80 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.44 129.19 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.46 108.95 16.66 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.82 153.61 40.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.3 p -55.31 -39.27 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.77 -25.74 14.95 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.972 0.351 . . . . 0.0 111.539 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -118.21 126.62 52.56 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.579 0.549 . . . . 0.0 111.576 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.66 119.57 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.88 -175.88 26.99 Favored Glycine 0 CA--C 1.536 1.349 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.1 157.07 63.52 Favored 'Trans proline' 0 N--CA 1.508 2.34 0 C-N-CA 122.546 2.164 . . . . 0.0 112.431 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -64.96 126.18 27.2 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.299 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -77.82 -1.02 29.5 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.027 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -92.89 129.87 38.66 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.881 0.472 . . . . 0.0 110.576 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.409 ' H ' ' H ' ' A' ' 158' ' ' PHE . 89.9 mtt-85 -150.36 -11.91 0.25 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.409 ' H ' ' H ' ' A' ' 157' ' ' ARG . 9.4 t80 . . . . . 0 N--CA 1.472 0.665 0 C-N-CA 123.868 0.867 . . . . 0.0 108.817 178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.84 132.23 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -116.25 109.22 17.11 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 120.541 0.21 . . . . 0.0 110.952 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.03 153.19 40.18 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.33 -38.95 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.14 -25.53 14.88 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.866 0.303 . . . . 0.0 111.455 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -118.05 126.39 52.2 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.665 0.603 . . . . 0.0 111.551 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.6 t -132.3 119.26 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.73 -175.08 27.24 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.26 154.84 72.93 Favored 'Trans proline' 0 N--CA 1.506 2.243 0 C-N-CA 122.411 2.074 . . . . 0.0 112.36 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -64.36 128.56 36.3 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.338 1.055 . . . . 0.0 112.271 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -80.0 -1.03 37.88 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.778 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -94.59 131.64 40.15 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.059 0.544 . . . . 0.0 110.468 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.418 ' H ' ' H ' ' A' ' 158' ' ' PHE . 38.6 ptt180 -155.8 -9.84 0.11 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.745 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.418 ' H ' ' H ' ' A' ' 157' ' ' ARG . 7.0 t80 . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 . . . . . 0 N--CA 1.486 1.348 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.77 127.95 75.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.903 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -116.63 110.98 19.22 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 120.952 0.406 . . . . 0.0 110.486 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.41 156.22 37.49 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.9 m -55.47 -40.43 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.68 -25.56 15.51 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.337 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -118.64 128.34 54.44 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.737 0.648 . . . . 0.0 111.872 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.73 119.33 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.7 -174.95 30.69 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 156.45 65.56 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 122.425 2.084 . . . . 0.0 112.124 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.81 123.58 19.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.921 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -76.13 -0.98 23.95 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.826 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -93.39 134.89 35.16 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.997 0.519 . . . . 0.0 109.945 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.411 ' H ' ' H ' ' A' ' 158' ' ' PHE . 40.9 ttm180 -154.99 -14.9 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.947 0.499 . . . . 0.0 109.892 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.411 ' H ' ' H ' ' A' ' 157' ' ' ARG . 8.3 t80 . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.1 129.34 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -116.5 109.88 17.86 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.79 154.99 38.76 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.0 m -55.81 -39.63 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.2 -25.48 15.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.519 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -118.45 128.15 54.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.559 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.3 t -132.57 119.33 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 150.97 -175.36 29.97 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.49 160.59 48.99 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 122.457 2.105 . . . . 0.0 112.315 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.77 125.86 26.11 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.613 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -81.37 -0.73 42.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.064 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -96.88 107.39 19.89 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.274 0.629 . . . . 0.0 110.989 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 34.0 mtm105 -131.15 -6.04 3.87 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.119 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.7 t80 . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.674 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 . . . . . 0 N--CA 1.485 1.324 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.82 130.05 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.37 109.52 17.45 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.727 0.239 . . . . 0.0 110.805 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.16 153.11 42.01 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.73 -40.39 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.51 -25.79 16.07 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.517 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -118.38 126.88 53.02 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.514 0.509 . . . . 0.0 111.623 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.6 119.2 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 145.64 -177.63 23.91 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.88 154.24 51.48 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 122.531 2.154 . . . . 0.0 112.909 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -64.75 126.78 29.02 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.146 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -75.94 -1.34 25.08 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.965 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -95.23 132.25 40.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.061 0.544 . . . . 0.0 111.131 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.43 ' H ' ' H ' ' A' ' 158' ' ' PHE . 11.6 ptp180 -155.95 -8.69 0.11 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.43 ' H ' ' H ' ' A' ' 157' ' ' ARG . 4.8 t80 . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.63 130.28 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 146' ' ' GLU . 0.5 OUTLIER -116.46 109.88 17.88 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 121.098 0.475 . . . . 0.0 111.477 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.74 153.2 41.24 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.8 m -55.47 -39.97 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.09 -25.57 15.83 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.835 0.289 . . . . 0.0 111.494 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -118.93 128.01 54.02 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.594 0.559 . . . . 0.0 111.671 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.6 119.32 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 148.96 -175.16 28.34 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.69 156.77 62.67 Favored 'Trans proline' 0 N--CA 1.508 2.328 0 C-N-CA 122.595 2.196 . . . . 0.0 112.268 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -64.84 125.08 23.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.218 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -77.62 -0.87 28.2 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.906 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -93.67 133.85 36.59 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.822 0.449 . . . . 0.0 110.433 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ARG . . . . . 0.424 ' H ' ' H ' ' A' ' 158' ' ' PHE . 76.5 ttt180 -155.53 -11.41 0.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.424 ' H ' ' H ' ' A' ' 157' ' ' ARG . 5.5 t80 . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -161.71 75.14 2.37 Favored Pre-proline 0 CA--C 1.552 1.05 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -86.33 179.61 3.49 Favored 'Trans proline' 0 N--CA 1.502 2.021 0 C-N-CA 122.647 2.232 . . . . 0.0 111.034 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 -70.55 -136.04 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 54.15 62.65 2.49 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.598 0.359 . . . . 0.0 111.253 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 34.2 t-105 -126.4 119.25 26.81 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.32 130.68 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -116.28 110.31 18.57 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 120.851 0.358 . . . . 0.0 111.283 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.19 152.52 44.4 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.55 -40.15 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -176.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.23 -25.84 15.65 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.393 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -118.51 126.37 51.86 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 123.505 0.503 . . . . 0.0 111.261 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.1 t -132.64 119.31 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 148.9 -174.3 28.57 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.8 155.39 68.82 Favored 'Trans proline' 0 N--CA 1.508 2.351 0 C-N-CA 122.614 2.21 . . . . 0.0 112.293 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -64.58 127.65 32.42 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.2 1.0 . . . . 0.0 112.459 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 76.1 mtm180 -78.36 -1.08 31.6 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.076 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -92.73 132.18 37.16 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 122.788 0.435 . . . . 0.0 110.473 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.414 ' H ' ' H ' ' A' ' 158' ' ' PHE . 39.3 ttm180 -155.41 -13.03 0.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.227 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.414 ' H ' ' H ' ' A' ' 157' ' ' ARG . 10.7 t80 -114.46 148.19 38.18 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 177.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.479 HD22 ' N ' ' A' ' 160' ' ' SER . 0.3 OUTLIER -146.79 117.42 7.55 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.479 ' N ' HD22 ' A' ' 159' ' ' ASN . 45.2 t -108.51 109.04 20.2 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.249 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.69 -12.01 60.32 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 121.063 1.756 . . . . 0.0 110.586 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -105.57 32.4 4.33 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.328 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -70.54 120.1 15.67 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.696 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -103.78 99.13 8.91 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 161.28 -179.52 36.66 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.23 134.62 21.33 Favored 'Trans proline' 0 N--CA 1.511 2.525 0 C-N-CA 122.454 2.103 . . . . 0.0 112.122 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -96.18 141.45 29.53 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.9 0.88 . . . . 0.0 108.639 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.12 14.55 1.67 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 118.634 0.652 . . . . 0.0 111.938 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -94.46 134.88 36.51 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 118.092 0.406 . . . . 0.0 111.59 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -58.89 -31.65 68.79 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.659 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.41 -3.22 35.85 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.037 -177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -87.59 4.2 44.67 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.18 131.67 43.7 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.424 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 67.3 m . . . . . 0 N--CA 1.476 0.854 0 CA-C-O 117.969 -1.015 . . . . 0.0 111.009 -179.931 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -64.53 119.5 57.44 Favored Pre-proline 0 CA--C 1.556 1.182 0 CA-C-O 118.51 -0.757 . . . . 0.0 109.56 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -78.64 -124.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.508 2.371 0 C-N-CA 121.706 1.604 . . . . 0.0 111.235 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -146.87 47.6 1.16 Allowed 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -124.82 43.81 2.94 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.462 -179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.3 t-105 -114.39 119.99 38.82 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.96 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.52 130.17 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.34 109.5 17.44 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.65 154.65 39.06 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.18 -37.62 44.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -176.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.42 -25.78 14.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 120.947 -0.301 . . . . 0.0 111.599 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -118.65 128.73 54.8 Favored 'General case' 0 N--CA 1.476 0.87 0 O-C-N 123.695 0.622 . . . . 0.0 111.744 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 54.8 t -134.46 119.22 29.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.65 -177.58 25.83 Favored Glycine 0 CA--C 1.534 1.256 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -59.85 153.53 56.25 Favored 'Trans proline' 0 N--CA 1.506 2.231 0 C-N-CA 122.383 2.056 . . . . 0.0 113.035 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -65.48 126.04 27.06 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.665 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -77.11 -1.06 27.28 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.048 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -94.69 133.33 38.48 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.046 0.539 . . . . 0.0 110.769 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.415 ' H ' ' H ' ' A' ' 158' ' ' PHE . 27.7 ttp-105 -155.61 -10.45 0.11 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.383 0.673 . . . . 0.0 109.262 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.415 ' H ' ' H ' ' A' ' 157' ' ' ARG . 8.3 t80 -114.16 148.06 37.86 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.442 HD22 ' N ' ' A' ' 160' ' ' SER . 0.4 OUTLIER -141.72 116.83 9.99 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 177.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.442 ' N ' HD22 ' A' ' 159' ' ' ASN . 47.7 t -108.94 104.61 13.88 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.242 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.6 -11.73 60.27 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 121.177 1.808 . . . . 0.0 110.686 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -105.73 31.96 4.66 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 114.876 -1.056 . . . . 0.0 109.699 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -70.45 119.04 14.03 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -103.57 99.18 8.99 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 161.93 178.37 35.77 Favored Glycine 0 CA--C 1.536 1.397 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -73.45 134.2 20.28 Favored 'Trans proline' 0 N--CA 1.508 2.378 0 C-N-CA 122.304 2.003 . . . . 0.0 111.896 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -97.41 141.54 30.36 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -143.86 15.12 1.74 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 118.362 0.528 . . . . 0.0 111.734 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -94.16 133.55 37.55 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.035 0.38 . . . . 0.0 111.632 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -58.3 -30.44 66.66 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.635 178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.25 -3.21 38.62 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.157 -177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -90.19 3.92 52.06 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.45 133.06 42.53 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.065 -0.971 . . . . 0.0 109.78 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.815 179.581 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -165.24 59.62 0.65 Allowed Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.422 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -81.87 160.47 18.63 Favored 'Trans proline' 0 N--CA 1.503 2.079 0 C-N-CA 122.104 1.869 . . . . 0.0 110.873 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 64.3 mtp85 -69.73 -138.84 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 53.24 72.51 0.42 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 122.808 0.443 . . . . 0.0 111.359 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 33.2 t-105 -126.2 120.16 29.33 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -115.69 131.63 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -116.41 109.06 16.82 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 120.828 0.347 . . . . 0.0 110.884 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.99 153.81 40.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.6 m -55.32 -38.26 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 -176.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.62 -25.72 14.63 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.416 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -118.88 127.77 53.82 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 123.602 0.564 . . . . 0.0 111.88 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.22 119.32 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 146.32 -176.62 25.15 Favored Glycine 0 CA--C 1.535 1.307 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.06 151.7 70.58 Favored 'Trans proline' 0 N--CA 1.507 2.317 0 C-N-CA 122.417 2.078 . . . . 0.0 112.854 179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -64.38 129.48 40.07 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.743 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -78.99 -1.1 33.84 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.872 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -95.55 131.77 41.39 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.228 0.611 . . . . 0.0 110.681 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.416 ' H ' ' H ' ' A' ' 158' ' ' PHE . 16.0 ptm180 -155.74 -7.57 0.12 Allowed 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.257 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.416 ' H ' ' H ' ' A' ' 157' ' ' ARG . 3.8 t80 -114.04 147.98 37.79 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.458 HD22 ' N ' ' A' ' 160' ' ' SER . 0.3 OUTLIER -140.68 116.39 10.26 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 178.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.458 ' N ' HD22 ' A' ' 159' ' ' ASN . 43.1 t -108.84 104.79 14.11 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.3 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.73 -11.85 60.27 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 121.185 1.811 . . . . 0.0 110.681 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -106.7 32.43 4.54 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.742 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -67.81 121.69 16.53 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -177.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -103.85 99.27 9.04 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 154.57 169.53 19.37 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.52 133.84 57.19 Favored 'Trans proline' 0 N--CA 1.514 2.728 0 C-N-CA 122.193 1.929 . . . . 0.0 112.735 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -97.95 142.1 30.1 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.126 0.97 . . . . 0.0 108.606 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.24 14.63 2.22 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 118.735 0.698 . . . . 0.0 112.326 -179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -93.48 133.7 36.51 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.179 0.445 . . . . 0.0 111.287 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 8.7 mtmp? -57.57 -30.78 65.53 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.438 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.59 -2.95 38.33 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.708 -0.678 . . . . 0.0 112.208 -177.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -87.31 4.4 43.0 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.921 0.488 . . . . 0.0 110.151 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -95.78 129.64 42.95 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.475 0.81 0 CA-C-O 118.175 -0.916 . . . . 0.0 110.363 -179.697 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.5 t . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -165.39 67.0 1.17 Allowed Pre-proline 0 CA--C 1.552 1.044 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -81.73 -121.19 0.01 OUTLIER 'Trans proline' 0 N--CA 1.504 2.133 0 C-N-CA 122.57 2.18 . . . . 0.0 112.791 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 89.5 mtm-85 -84.44 127.91 34.28 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 -177.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 63.24 45.49 5.02 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.215 1.006 . . . . 0.0 112.653 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 38.1 t-105 -127.18 117.76 22.97 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.538 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.2 p -110.58 129.9 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -116.19 108.31 15.98 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 117.672 0.215 . . . . 0.0 110.677 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.21 152.1 41.59 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.3 m -55.56 -40.08 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.7 -25.55 16.06 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 117.818 0.281 . . . . 0.0 111.748 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -118.62 126.18 51.38 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 123.575 0.547 . . . . 0.0 111.375 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 52.7 t -130.78 119.33 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 144.06 -177.12 22.94 Favored Glycine 0 CA--C 1.538 1.499 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.4 153.94 50.63 Favored 'Trans proline' 0 N--CA 1.513 2.656 0 C-N-CA 122.891 2.394 . . . . 0.0 113.599 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -65.2 128.31 35.28 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.364 1.065 . . . . 0.0 112.41 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.9 mtm180 -81.0 -1.0 42.06 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.97 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -92.94 129.44 38.85 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.914 0.486 . . . . 0.0 110.857 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.44 ' H ' ' H ' ' A' ' 158' ' ' PHE . 34.1 ptt180 -155.95 -9.53 0.11 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.377 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.44 ' H ' ' H ' ' A' ' 157' ' ' ARG . 9.2 t80 -114.83 148.05 39.03 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 178.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.05 117.96 8.21 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.8 t -108.56 105.81 15.6 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 118.286 -0.864 . . . . 0.0 109.733 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.79 -11.83 60.51 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.806 1.639 . . . . 0.0 110.971 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -104.45 30.26 5.47 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.056 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -70.6 118.45 13.41 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.792 -0.186 . . . . 0.0 111.319 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 4.2 ptpp? -103.55 99.22 9.03 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 158.37 169.51 21.96 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -57.49 133.53 57.5 Favored 'Trans proline' 0 N--CA 1.516 2.851 0 C-N-CA 122.107 1.871 . . . . 0.0 113.128 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -96.25 141.91 29.03 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.095 0.958 . . . . 0.0 108.604 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.08 14.24 2.24 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 118.607 0.64 . . . . 0.0 112.101 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -96.05 135.36 37.94 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-O 121.054 0.454 . . . . 0.0 111.753 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 29.4 mmtp -59.55 -31.06 69.07 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.818 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.55 -3.25 39.7 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.113 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -86.85 4.37 41.55 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.27 130.35 43.38 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.369 -0.832 . . . . 0.0 108.789 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.986 -179.638 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 53.64 76.82 0.49 Allowed Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.438 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.31 171.8 0.52 Allowed 'Trans proline' 0 N--CA 1.513 2.668 0 C-N-CA 122.236 1.957 . . . . 0.0 112.44 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -69.6 125.22 26.06 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.752 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 61.12 44.16 10.4 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.422 0.689 . . . . 0.0 111.68 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -126.66 119.78 27.86 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 123.397 0.436 . . . . 0.0 112.089 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.7 p -112.44 129.19 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -116.46 108.95 16.66 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.82 153.61 40.77 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.3 p -55.31 -39.27 51.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -176.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.77 -25.74 14.95 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 117.972 0.351 . . . . 0.0 111.539 -178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 57.5 t80 -118.21 126.62 52.56 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.579 0.549 . . . . 0.0 111.576 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.2 t -132.66 119.57 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.88 -175.88 26.99 Favored Glycine 0 CA--C 1.536 1.349 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.1 157.07 63.52 Favored 'Trans proline' 0 N--CA 1.508 2.34 0 C-N-CA 122.546 2.164 . . . . 0.0 112.431 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -64.96 126.18 27.2 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.299 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 86.0 mtm180 -77.82 -1.02 29.5 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.027 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -92.89 129.87 38.66 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 122.881 0.472 . . . . 0.0 110.576 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.409 ' H ' ' H ' ' A' ' 158' ' ' PHE . 89.9 mtt-85 -150.36 -11.91 0.25 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.409 ' H ' ' H ' ' A' ' 157' ' ' ARG . 9.4 t80 -114.76 148.0 38.97 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.868 0.867 . . . . 0.0 108.817 178.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -145.85 117.27 7.98 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 40.7 t -108.76 107.29 17.68 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.188 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.29 -11.77 60.36 Favored 'General case' 0 N--CA 1.482 1.149 0 CA-C-N 121.142 1.792 . . . . 0.0 110.224 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -105.23 32.7 4.07 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.471 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -69.93 120.1 15.15 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.587 -0.278 . . . . 0.0 111.744 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 34.8 pttt -103.89 99.07 8.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 159.49 -179.19 35.25 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 110.402 -1.079 . . . . 0.0 110.402 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -73.23 134.31 20.82 Favored 'Trans proline' 0 N--CA 1.509 2.424 0 C-N-CA 122.438 2.092 . . . . 0.0 111.928 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -96.77 141.91 29.42 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.02 15.35 1.9 Allowed 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 118.557 0.617 . . . . 0.0 112.141 -178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -95.17 134.86 37.44 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 118.09 0.405 . . . . 0.0 111.452 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -58.57 -32.05 68.57 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.766 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -76.39 -3.28 36.15 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.227 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -89.58 4.35 49.64 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.841 0.456 . . . . 0.0 109.833 178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.46 133.6 40.68 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.52 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 73.8 m . . . . . 0 N--CA 1.473 0.724 0 CA-C-O 118.264 -0.874 . . . . 0.0 109.893 -179.935 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.9 t . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -69.21 148.69 97.55 Favored Pre-proline 0 CA--C 1.555 1.137 0 CA-C-O 118.867 -0.587 . . . . 0.0 110.347 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -78.45 170.24 18.72 Favored 'Trans proline' 0 N--CA 1.507 2.316 0 C-N-CA 121.808 1.672 . . . . 0.0 110.563 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -72.69 -134.89 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 52.03 66.2 1.27 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.563 0.345 . . . . 0.0 110.654 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 30.7 t-105 -126.68 119.72 27.69 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.3 p -113.84 132.23 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -116.25 109.22 17.11 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 120.541 0.21 . . . . 0.0 110.952 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.03 153.19 40.18 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.33 -38.95 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -176.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.14 -25.53 14.88 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.866 0.303 . . . . 0.0 111.455 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -118.05 126.39 52.2 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 123.665 0.603 . . . . 0.0 111.551 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.6 t -132.3 119.26 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 147.73 -175.08 27.24 Favored Glycine 0 CA--C 1.534 1.239 0 N-CA-C 110.348 -1.101 . . . . 0.0 110.348 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.26 154.84 72.93 Favored 'Trans proline' 0 N--CA 1.506 2.243 0 C-N-CA 122.411 2.074 . . . . 0.0 112.36 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -64.36 128.56 36.3 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.338 1.055 . . . . 0.0 112.271 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -80.0 -1.03 37.88 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.778 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -94.59 131.64 40.15 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.059 0.544 . . . . 0.0 110.468 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.418 ' H ' ' H ' ' A' ' 158' ' ' PHE . 38.6 ptt180 -155.8 -9.84 0.11 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.745 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.418 ' H ' ' H ' ' A' ' 157' ' ' ARG . 7.0 t80 -114.66 112.77 23.4 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -103.93 116.61 32.57 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 35.5 t -108.85 103.83 12.97 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 118.277 -0.868 . . . . 0.0 109.917 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.86 -12.05 60.28 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 120.829 1.65 . . . . 0.0 110.497 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -105.59 31.19 5.15 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.603 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -73.62 119.3 17.66 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 116.978 -0.101 . . . . 0.0 110.952 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 21.4 pttm -103.76 100.33 10.14 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 121.173 0.511 . . . . 0.0 110.2 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 160.55 179.47 35.34 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.79 134.62 32.99 Favored 'Trans proline' 0 N--CA 1.516 2.807 0 C-N-CA 122.152 1.901 . . . . 0.0 112.556 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.32 142.1 27.7 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.56 11.25 2.72 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 118.596 0.635 . . . . 0.0 111.447 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -93.83 134.08 36.57 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 120.639 0.257 . . . . 0.0 111.081 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -57.35 -32.1 66.4 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 123.171 0.588 . . . . 0.0 112.151 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.92 -3.11 33.61 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.33 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -86.56 4.74 38.8 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.22 0.608 . . . . 0.0 110.164 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -95.96 130.37 42.96 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.476 0.849 0 CA-C-O 118.041 -0.98 . . . . 0.0 111.667 -179.292 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 89.4 p . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.8 tttt 56.13 60.7 8.17 Favored Pre-proline 0 CA--C 1.555 1.144 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.271 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -88.32 -174.47 1.12 Allowed 'Trans proline' 0 N--CA 1.501 1.956 0 C-N-CA 122.636 2.224 . . . . 0.0 111.129 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -66.25 -137.62 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.178 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 55.95 53.13 9.59 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 119.092 0.86 . . . . 0.0 110.565 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 35.5 t-105 -117.26 122.79 44.95 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -177.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.77 127.95 75.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.903 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -116.63 110.98 19.22 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 120.952 0.406 . . . . 0.0 110.486 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.41 156.22 37.49 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.9 m -55.47 -40.43 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 113.956 1.095 . . . . 0.0 113.956 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.68 -25.56 15.51 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.337 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -118.64 128.34 54.44 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.737 0.648 . . . . 0.0 111.872 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.73 119.33 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.7 -174.95 30.69 Favored Glycine 0 CA--C 1.534 1.222 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.5 156.45 65.56 Favored 'Trans proline' 0 N--CA 1.505 2.182 0 C-N-CA 122.425 2.084 . . . . 0.0 112.124 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -64.81 123.58 19.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.921 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -76.13 -0.98 23.95 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.826 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -93.39 134.89 35.16 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.997 0.519 . . . . 0.0 109.945 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.411 ' H ' ' H ' ' A' ' 158' ' ' PHE . 40.9 ttm180 -154.99 -14.9 0.12 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 122.947 0.499 . . . . 0.0 109.892 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.411 ' H ' ' H ' ' A' ' 157' ' ' ARG . 8.3 t80 -114.4 147.87 38.56 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.72 116.42 12.19 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 48.4 t -109.05 104.06 13.2 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.391 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.95 -11.84 60.21 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 121.054 1.752 . . . . 0.0 110.909 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -104.93 30.57 5.42 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.141 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.4 t80 -74.27 117.97 16.69 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.666 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -102.9 99.27 9.18 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 166.51 -179.24 40.58 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.89 132.48 18.48 Favored 'Trans proline' 0 N--CA 1.507 2.272 0 C-N-CA 121.963 1.775 . . . . 0.0 111.414 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -97.69 142.05 29.96 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.062 0.945 . . . . 0.0 108.679 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.13 16.91 1.55 Allowed 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 118.453 0.57 . . . . 0.0 111.96 -179.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -97.75 137.49 36.55 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 118.095 0.407 . . . . 0.0 111.611 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -62.04 -28.87 69.9 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.35 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.52 -2.93 48.13 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -89.81 3.95 51.3 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -98.31 133.94 42.02 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.586 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.8 t . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 118.037 -0.982 . . . . 0.0 111.627 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 95.4 p . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.53 ' H ' ' CD ' ' A' ' 141' ' ' PRO . 64.3 tttm -163.34 -42.75 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.128 0 CA-C-O 118.596 -0.716 . . . . 0.0 111.558 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.53 ' CD ' ' H ' ' A' ' 140' ' ' LYS . 13.1 Cg_endo -94.75 -112.37 0.0 OUTLIER 'Trans proline' 0 N--CA 1.504 2.098 0 C-N-CA 122.39 2.06 . . . . 0.0 111.819 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.0 ptm180 -135.48 -130.83 0.15 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.852 0.861 . . . . 0.0 108.816 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 57.27 47.56 16.64 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 118.425 0.557 . . . . 0.0 109.591 -178.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.1 t-105 -119.71 119.9 35.01 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 -176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.1 p -113.1 129.34 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -116.5 109.88 17.86 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.79 154.99 38.76 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 35.0 m -55.81 -39.63 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -176.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -97.2 -25.48 15.28 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.519 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -118.45 128.15 54.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.559 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.3 t -132.57 119.33 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 150.97 -175.36 29.97 Favored Glycine 0 CA--C 1.531 1.069 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -70.49 160.59 48.99 Favored 'Trans proline' 0 N--CA 1.502 2.005 0 C-N-CA 122.457 2.105 . . . . 0.0 112.315 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -64.77 125.86 26.11 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.613 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -81.37 -0.73 42.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.064 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -96.88 107.39 19.89 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.274 0.629 . . . . 0.0 110.989 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 34.0 mtm105 -131.15 -6.04 3.87 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.119 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -114.51 147.88 38.73 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -142.82 118.65 10.54 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 46.8 t -108.5 105.9 15.76 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 118.21 -0.9 . . . . 0.0 109.09 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.73 -11.56 60.2 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 120.885 1.675 . . . . 0.0 111.138 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -108.63 30.67 6.26 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.992 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -65.76 117.57 8.36 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -176.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -102.42 99.28 9.32 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 178.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 161.75 -179.92 36.82 Favored Glycine 0 CA--C 1.536 1.36 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.4 132.8 18.18 Favored 'Trans proline' 0 N--CA 1.508 2.381 0 C-N-CA 122.329 2.02 . . . . 0.0 111.781 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -94.6 140.8 29.37 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.58 14.2 2.15 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.334 0.515 . . . . 0.0 111.659 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -93.87 131.38 39.33 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-N 118.015 0.37 . . . . 0.0 110.787 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -58.31 -27.72 64.36 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.655 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.59 -2.98 48.62 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.252 -177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -89.54 3.75 51.49 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -97.8 129.17 44.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.07 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 87.0 p . . . . . 0 N--CA 1.475 0.789 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.07 -179.878 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.9 t . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.471 ' N ' ' CD ' ' A' ' 141' ' ' PRO . 97.1 mttt -83.55 -34.75 0.6 Allowed Pre-proline 0 CA--C 1.554 1.114 0 CA-C-O 118.7 -0.667 . . . . 0.0 111.882 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 140' ' ' LYS . 25.1 Cg_endo -92.65 179.6 1.19 Allowed 'Trans proline' 0 N--CA 1.502 1.999 0 C-N-CA 122.331 2.02 . . . . 0.0 112.177 -179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -65.83 -132.17 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.367 179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 52.16 65.83 1.39 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 119.162 0.892 . . . . 0.0 110.467 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.7 t-105 -126.29 121.42 32.58 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.4 p -113.82 130.05 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -116.37 109.52 17.45 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.727 0.239 . . . . 0.0 110.805 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -124.16 153.11 42.01 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.2 m -55.73 -40.39 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -176.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.51 -25.79 16.07 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 120.924 -0.31 . . . . 0.0 111.517 -178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -118.38 126.88 53.02 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 123.514 0.509 . . . . 0.0 111.623 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 52.9 t -132.6 119.2 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 145.64 -177.63 23.91 Favored Glycine 0 CA--C 1.537 1.414 0 N-CA-C 111.214 -0.754 . . . . 0.0 111.214 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.88 154.24 51.48 Favored 'Trans proline' 0 N--CA 1.508 2.342 0 C-N-CA 122.531 2.154 . . . . 0.0 112.909 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -64.75 126.78 29.02 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.033 -0.985 . . . . 0.0 112.146 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -75.94 -1.34 25.08 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.965 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -95.23 132.25 40.39 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.061 0.544 . . . . 0.0 111.131 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.43 ' H ' ' H ' ' A' ' 158' ' ' PHE . 11.6 ptp180 -155.95 -8.69 0.11 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.43 ' H ' ' H ' ' A' ' 157' ' ' ARG . 4.8 t80 -114.55 148.01 38.62 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.57 118.3 6.18 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 178.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.9 t -108.4 110.2 21.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.805 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.72 -11.8 60.26 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 120.878 1.672 . . . . 0.0 110.839 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -106.16 31.73 4.92 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.52 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -72.47 115.29 11.56 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.699 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -100.75 99.04 9.52 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 165.77 -179.72 39.87 Favored Glycine 0 CA--C 1.537 1.456 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.02 133.51 19.88 Favored 'Trans proline' 0 N--CA 1.51 2.446 0 C-N-CA 122.172 1.915 . . . . 0.0 111.738 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -97.31 141.59 30.22 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -142.69 15.0 1.96 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 118.64 0.655 . . . . 0.0 112.083 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -94.52 134.7 36.79 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 118.049 0.386 . . . . 0.0 111.489 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -58.94 -30.56 67.96 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.904 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.84 -3.08 39.74 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.142 -177.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -87.66 4.6 43.35 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.042 0.537 . . . . 0.0 109.646 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.71 130.43 43.94 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.005 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 54.9 p . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 117.96 -1.019 . . . . 0.0 111.667 -179.567 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -53.78 112.41 3.73 Favored Pre-proline 0 CA--C 1.56 1.341 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.96 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -87.12 172.16 6.32 Favored 'Trans proline' 0 N--CA 1.505 2.164 0 C-N-CA 122.111 1.874 . . . . 0.0 111.268 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -71.45 -136.0 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 53.96 65.34 1.54 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 122.625 0.37 . . . . 0.0 111.3 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 32.9 t-105 -126.19 118.72 25.77 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -177.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.6 p -112.63 130.28 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.402 ' H ' ' CD ' ' A' ' 146' ' ' GLU . 0.5 OUTLIER -116.46 109.88 17.88 Favored 'General case' 0 N--CA 1.481 1.075 0 CA-C-O 121.098 0.475 . . . . 0.0 111.477 -179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -123.74 153.2 41.24 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 34.8 m -55.47 -39.97 56.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -176.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -96.09 -25.57 15.83 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 117.835 0.289 . . . . 0.0 111.494 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -118.93 128.01 54.02 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 123.594 0.559 . . . . 0.0 111.671 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.1 t -132.6 119.32 38.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 176.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 148.96 -175.16 28.34 Favored Glycine 0 CA--C 1.534 1.248 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.69 156.77 62.67 Favored 'Trans proline' 0 N--CA 1.508 2.328 0 C-N-CA 122.595 2.196 . . . . 0.0 112.268 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -64.84 125.08 23.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.218 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -77.62 -0.87 28.2 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.906 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -93.67 133.85 36.59 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.822 0.449 . . . . 0.0 110.433 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . 0.424 ' H ' ' H ' ' A' ' 158' ' ' PHE . 76.5 ttt180 -155.53 -11.41 0.11 Allowed 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.424 ' H ' ' H ' ' A' ' 157' ' ' ARG . 5.5 t80 -114.0 147.81 38.0 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.48 HD22 ' N ' ' A' ' 160' ' ' SER . 0.2 OUTLIER -142.72 116.04 9.01 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 177.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.48 ' N ' HD22 ' A' ' 159' ' ' ASN . 46.9 t -108.87 104.82 14.14 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 118.198 -0.906 . . . . 0.0 110.206 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.16 -11.5 60.31 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 121.123 1.783 . . . . 0.0 110.343 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -105.54 32.27 4.41 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.33 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -71.14 119.68 15.61 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.284 0.475 . . . . 0.0 112.284 -177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -103.48 98.9 8.72 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 161.85 178.97 36.21 Favored Glycine 0 CA--C 1.538 1.507 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -73.68 134.44 20.23 Favored 'Trans proline' 0 N--CA 1.511 2.524 0 C-N-CA 122.385 2.057 . . . . 0.0 112.088 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -97.6 142.11 29.82 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.007 0.923 . . . . 0.0 108.887 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.27 15.4 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 118.676 0.671 . . . . 0.0 111.82 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -93.9 133.64 37.1 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 120.753 0.311 . . . . 0.0 111.521 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -58.97 -30.43 67.92 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.952 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.78 -3.48 41.58 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.015 -177.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -89.84 4.35 50.12 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.997 0.519 . . . . 0.0 109.776 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -95.09 132.12 40.34 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.269 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 96.9 p . . . . . 0 N--CA 1.475 0.8 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.781 -179.729 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' C2E . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_